5OCO

Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method.

5OCO の概要

• エントリーDOI: 10.2210/pdb5oco/pdb
• 分子名称: GTPase KRas, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, ~{N}-[[(3~{R})-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]furan-2-carboxamide, ... (7 entities in total)
• 機能のキーワード: domain antibodies, small molecules, drug fragment screening, hydrolase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 6
• 化学式量合計: 134246.77

構造登録者

Cruz-Migoni, A.,Ehebauer, M.T.,Phillips, S.E.V.,Quevedo, C.E.,Rabbitts, T.H. (登録日: 2017-07-03, 公開日: 2018-08-22, 最終更新日: 2024-01-17)

• 主引用文献: Quevedo, C.E.,Cruz-Migoni, A.,Bery, N.,Miller, A.,Tanaka, T.,Petch, D.,Bataille, C.J.R.,Lee, L.Y.W.,Fallon, P.S.,Tulmin, H.,Ehebauer, M.T.,Fernandez-Fuentes, N.,Russell, A.J.,Carr, S.B.,Phillips, S.E.V.,Rabbitts, T.H.; Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment.; Nat Commun, 9:3169-3169, 2018; PubMed: 30093669; DOI: 10.1038/s41467-018-05707-2

実験手法

X-RAY DIFFRACTION (1.66 Å)